Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-11-18

Clinical Trial Update: AD-SVF Therapy for Refractory Endometrial Infertility [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating adipose-derived stromal vascular fraction (AD-SVF) therapy for refractory endometrial infertility is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AD-SVF Therapy

Snippet

Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | Conditions: Endometrium; Atrophy, Intrauterine Synechiae | Phase 1 | Status: RECRUITING